CA1140466A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- CA1140466A CA1140466A CA000368219A CA368219A CA1140466A CA 1140466 A CA1140466 A CA 1140466A CA 000368219 A CA000368219 A CA 000368219A CA 368219 A CA368219 A CA 368219A CA 1140466 A CA1140466 A CA 1140466A
- Authority
- CA
- Canada
- Prior art keywords
- amount
- agent
- pharmaceutical composition
- sustained release
- per tablet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11143080A | 1980-01-11 | 1980-01-11 | |
US111,430 | 1980-01-11 | ||
US194,453 | 1980-10-17 | ||
US06/194,453 US4308251A (en) | 1980-01-11 | 1980-10-17 | Controlled release formulations of orally-active medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1140466A true CA1140466A (en) | 1983-02-01 |
Family
ID=26808896
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000368219A Expired CA1140466A (en) | 1980-01-11 | 1981-01-09 | Pharmaceutical compositions |
Country Status (22)
Country | Link |
---|---|
JP (1) | JPS56103110A (fi) |
AT (1) | AT374681B (fi) |
AU (1) | AU542824B2 (fi) |
BE (1) | BE886998A (fi) |
CA (1) | CA1140466A (fi) |
CH (1) | CH646604A5 (fi) |
DE (1) | DE3100191A1 (fi) |
DK (1) | DK6181A (fi) |
ES (2) | ES498369A0 (fi) |
FI (1) | FI76927C (fi) |
FR (1) | FR2473308B1 (fi) |
GB (1) | GB2067072B (fi) |
GR (1) | GR73843B (fi) |
IE (1) | IE50806B1 (fi) |
IN (1) | IN151913B (fi) |
IT (1) | IT1221041B (fi) |
LU (1) | LU83052A1 (fi) |
NL (1) | NL8100037A (fi) |
NO (1) | NO156153C (fi) |
NZ (1) | NZ195933A (fi) |
SE (1) | SE447450B (fi) |
ZA (1) | ZA81136B (fi) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2496082A (en) * | 1947-05-24 | 1950-01-31 | Ashenfelter William | Scaffold structure |
IT1144911B (it) * | 1981-03-19 | 1986-10-29 | Pharmatec Spa | Composizione farmaceutica a rilascio controllato contenente ibuprofen |
JPS59227817A (ja) * | 1983-06-07 | 1984-12-21 | Toyo Jozo Co Ltd | 持続性経口用ブレデニン製剤 |
JPH0662404B2 (ja) * | 1983-06-14 | 1994-08-17 | シンテックス・ファーマシユーテイカルズ・インターナシヨナル・リミテツド | 制御放出性ナプロキセンおよびナプロキセンナトリウム錠 |
ZA836031B (en) * | 1983-08-16 | 1985-02-27 | Verex Lab | Constant release rate solid dosage theophylline formulation |
ZA836030B (en) * | 1983-08-16 | 1985-02-27 | Verex Lab | Constant order release solid dosage indomethacin formulation and method of treating arthritis and other inflammatory conditions |
DE3486029T2 (de) * | 1983-10-14 | 1993-05-13 | Sumitomo Pharma | Ifn-praeparat mit verzoegerter abgabe fuer parentale verabreichung. |
US5385738A (en) * | 1983-10-14 | 1995-01-31 | Sumitomo Pharmaceuticals Company, Ltd. | Sustained-release injection |
US4855134A (en) * | 1983-10-14 | 1989-08-08 | Sumitomo Pharmaceuticals Company, Limited | Sustained-release preparation |
US4774091A (en) * | 1983-10-14 | 1988-09-27 | Sumitomo Pharmaceuticals Company, Ltd. | Long-term sustained-release preparation |
ES2054613T3 (es) * | 1985-12-27 | 1994-08-16 | Sumitomo Pharma | Un metodo para preparar una formulacion de liberacion mantenida. |
GB8601204D0 (en) * | 1986-01-18 | 1986-02-19 | Boots Co Plc | Therapeutic agents |
IL85538A (en) * | 1987-02-27 | 1991-09-16 | Lilly Co Eli | Sustained release matrix tablet formulations containing hydrophilic and enteric polymers |
US4968508A (en) * | 1987-02-27 | 1990-11-06 | Eli Lilly And Company | Sustained release matrix |
WO1997002019A1 (en) | 1995-06-30 | 1997-01-23 | Baylor University | Polyester/carboxylic acid composite materials |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2953497A (en) * | 1953-06-03 | 1960-09-20 | Howard A Press | Therapeutic tablets |
BE604564A (fi) * | 1960-06-06 | |||
US3577514A (en) * | 1968-06-10 | 1971-05-04 | Pfizer | Sustained release pharmaceutical tablets |
US3773920A (en) * | 1971-07-14 | 1973-11-20 | Nikken Chemicals Co Ltd | Sustained release medicinal composition |
US3906086A (en) * | 1971-07-19 | 1975-09-16 | Richard G Powers | Timed-release aspirin |
GB1500300A (en) * | 1975-01-06 | 1978-02-08 | Ciba Geigy Ag | Pharmaceutical preparation for the treatment of circulatory disorders |
JPS5411226A (en) * | 1977-06-24 | 1979-01-27 | Shin Etsu Chem Co Ltd | Disintegratable granule |
-
1980
- 1980-12-23 IN IN1418/CAL/80A patent/IN151913B/en unknown
- 1980-12-23 NZ NZ195933A patent/NZ195933A/xx unknown
-
1981
- 1981-01-05 AU AU65976/81A patent/AU542824B2/en not_active Ceased
- 1981-01-06 FR FR8100087A patent/FR2473308B1/fr not_active Expired
- 1981-01-07 DE DE19813100191 patent/DE3100191A1/de active Granted
- 1981-01-07 NL NL8100037A patent/NL8100037A/nl not_active Application Discontinuation
- 1981-01-08 GB GB8100522A patent/GB2067072B/en not_active Expired
- 1981-01-08 ES ES498369A patent/ES498369A0/es active Granted
- 1981-01-08 DK DK6181A patent/DK6181A/da not_active Application Discontinuation
- 1981-01-08 JP JP157881A patent/JPS56103110A/ja active Pending
- 1981-01-08 CH CH9281A patent/CH646604A5/fr not_active IP Right Cessation
- 1981-01-08 BE BE0/203426A patent/BE886998A/fr unknown
- 1981-01-09 GR GR63828A patent/GR73843B/el unknown
- 1981-01-09 IE IE36/81A patent/IE50806B1/en unknown
- 1981-01-09 AT AT0005481A patent/AT374681B/de not_active IP Right Cessation
- 1981-01-09 ZA ZA00810136A patent/ZA81136B/xx unknown
- 1981-01-09 FI FI810056A patent/FI76927C/fi not_active IP Right Cessation
- 1981-01-09 CA CA000368219A patent/CA1140466A/en not_active Expired
- 1981-01-09 IT IT47537/81A patent/IT1221041B/it active
- 1981-01-09 LU LU83052A patent/LU83052A1/fr unknown
- 1981-01-09 NO NO810062A patent/NO156153C/no unknown
- 1981-01-09 SE SE8100104A patent/SE447450B/sv not_active IP Right Cessation
-
1982
- 1982-01-29 ES ES509179A patent/ES8301629A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR2473308B1 (fr) | 1985-07-19 |
NZ195933A (en) | 1982-11-23 |
FR2473308A1 (fr) | 1981-07-17 |
SE447450B (sv) | 1986-11-17 |
NO810062L (no) | 1981-07-13 |
DK6181A (da) | 1981-07-12 |
IT8147537A0 (it) | 1981-01-09 |
DE3100191A1 (de) | 1981-12-10 |
CH646604A5 (fr) | 1984-12-14 |
ZA81136B (en) | 1982-01-27 |
AT374681B (de) | 1984-05-25 |
GB2067072A (en) | 1981-07-22 |
FI810056L (fi) | 1981-07-12 |
JPS56103110A (en) | 1981-08-18 |
ES8205353A1 (es) | 1982-06-01 |
ES509179A0 (es) | 1982-12-16 |
IE50806B1 (en) | 1986-07-23 |
ES498369A0 (es) | 1982-06-01 |
AU542824B2 (en) | 1985-03-14 |
NL8100037A (nl) | 1981-08-03 |
GR73843B (fi) | 1984-05-07 |
FI76927B (fi) | 1988-09-30 |
NO156153C (no) | 1987-08-05 |
SE8100104L (sv) | 1981-07-12 |
NO156153B (no) | 1987-04-27 |
IN151913B (fi) | 1983-09-03 |
ATA5481A (de) | 1983-10-15 |
AU6597681A (en) | 1981-07-16 |
ES8301629A1 (es) | 1982-12-16 |
BE886998A (fr) | 1981-07-08 |
GB2067072B (en) | 1983-08-10 |
DE3100191C2 (fi) | 1988-09-01 |
IT1221041B (it) | 1990-06-21 |
IE810036L (en) | 1981-07-11 |
FI76927C (fi) | 1989-01-10 |
LU83052A1 (fr) | 1982-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4308251A (en) | Controlled release formulations of orally-active medicaments | |
CA1140466A (en) | Pharmaceutical compositions | |
AU604110B2 (en) | Ibuprofen sustained release matrix and process | |
AU616449B2 (en) | Controlled release combination of carbidopa/levodopa | |
US4375468A (en) | Constant order release aspirin composition and method of treating arthritis | |
US5529783A (en) | Rotor granulation and coating of acetaminophen, pseudoephedrine, chlorpheniramine, and, optionally dextromethorphan | |
US4900558A (en) | Sustained release ibuprofen formulation including a core of ibuprofen and a microcrystalline cellulose and a covering of acrylic polymer and hydroxylated cellulose derivative | |
EP0253490B1 (en) | Controlled release combination of carbidopa/levodopa | |
US4983400A (en) | Controlled release combination of carbidopa/levodopa | |
FI96095C (fi) | Menetelmä jatkuvavapautteisen lääkevalmisteen valmistamiseksi | |
EP0221732A2 (en) | Sustained release tablets | |
KR20090119993A (ko) | 구강내 붕괴정 | |
US4867987A (en) | Pharmaceutical product for the sustained release of ibuprofen | |
US3524910A (en) | Sustained relief analgesic compositions | |
US3039933A (en) | Ethyl cellulose-polyethylene glycol tablet matrix | |
US4601895A (en) | Delayed-action acetylsalicylic acid formulations for oral administration | |
EP1331972A2 (en) | Pharmaceutical compositions | |
JPS6087216A (ja) | 一定放出性固体投薬形インドメタシン組成物および関節炎その他の炎症性状態の治療法 | |
JP2638604B2 (ja) | 徐放性製剤 | |
JPH0899875A (ja) | ゲンフィブロジル含有製剤組成物およびその製造法 | |
CN116966157B (zh) | 一种茶碱缓释片及其制备方法 | |
JP3202775B2 (ja) | 固形製剤 | |
Kumar et al. | In vitro and in vivo studies on HPMC-K-100 M matrices containing naproxen sodium | |
SE452550B (sv) | Tablett med fordrojd frigoring av teofyllin | |
CN115721623A (zh) | 一种替格瑞洛片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKEX | Expiry |